Organigram Makes Groundbreaking Entry into German Cannabis Market

Canadian cannabis producer Organigram Holdings Inc. has made its first shipment of bulk dried flower to Sanity Group, entering the German medical cannabis market. The move comes as part of Organigram's strategy to offer high-quality products globally and establishes Sanity Group as its exclusive distributor for specific genetics, solidifying Organigram's position in one of the largest medical cannabis markets. This strategic expansion aims to strengthen Organigram's international presence and comes despite a challenging financial landscape. Analysts anticipate profitability for Organigram this year and view the move positively.